Verve Therapeutics Inc (VERV)
4.62
+0.07
(+1.54%)
USD |
NASDAQ |
Nov 21, 15:21
Verve Therapeutics Market Cap: 391.15M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 385.22M |
| November 19, 2024 | 409.77M |
| November 18, 2024 | 380.99M |
| November 15, 2024 | 405.54M |
| November 14, 2024 | 455.49M |
| November 13, 2024 | 490.20M |
| November 12, 2024 | 542.70M |
| November 11, 2024 | 543.54M |
| November 08, 2024 | 534.23M |
| November 07, 2024 | 538.46M |
| November 06, 2024 | 542.70M |
| November 05, 2024 | 540.16M |
| November 04, 2024 | 512.22M |
| November 01, 2024 | 502.06M |
| October 31, 2024 | 485.12M |
| October 30, 2024 | 490.20M |
| October 29, 2024 | 507.14M |
| October 28, 2024 | 502.75M |
| October 25, 2024 | 505.29M |
| October 24, 2024 | 484.13M |
| October 23, 2024 | 468.90M |
| October 22, 2024 | 481.59M |
| October 21, 2024 | 469.75M |
| October 18, 2024 | 478.21M |
| October 17, 2024 | 462.13M |
| Date | Value |
|---|---|
| October 16, 2024 | 473.98M |
| October 15, 2024 | 473.13M |
| October 14, 2024 | 425.73M |
| October 11, 2024 | 395.26M |
| October 10, 2024 | 389.34M |
| October 09, 2024 | 386.80M |
| October 08, 2024 | 382.57M |
| October 07, 2024 | 405.42M |
| October 04, 2024 | 423.19M |
| October 03, 2024 | 399.50M |
| October 02, 2024 | 406.27M |
| October 01, 2024 | 405.42M |
| September 30, 2024 | 409.65M |
| September 27, 2024 | 421.43M |
| September 26, 2024 | 419.74M |
| September 25, 2024 | 403.66M |
| September 24, 2024 | 418.89M |
| September 23, 2024 | 424.82M |
| September 20, 2024 | 439.20M |
| September 19, 2024 | 455.28M |
| September 18, 2024 | 466.28M |
| September 17, 2024 | 456.13M |
| September 16, 2024 | 458.66M |
| September 13, 2024 | 465.43M |
| September 12, 2024 | 478.13M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
372.35M
Minimum
Aug 14 2024
3.551B
Maximum
Sep 10 2021
1.259B
Average
1.114B
Median
Feb 22 2024
Market Cap Benchmarks
| Ardelyx Inc | 1.225B |
| Biomarin Pharmaceutical Inc | 12.15B |
| Sage Therapeutics Inc | 306.48M |
| ALX Oncology Holdings Inc | 68.04M |
| Immuneering Corp | 66.76M |
Market Cap Related Metrics
| PS Ratio | 15.81 |
| Price to Book Value | 0.7692 |
| Price | 4.62 |
| Earnings Yield | -53.25% |